6 insiders reported 58 Form 4 transactions for Century Therapeutics, Inc. (IPSC) over the past 18 months (most recent 2026-08-18). Recent activity: Pfeiffenberger Brent (President and CEO) Sell 31,172 shares, Carr Douglas (SVP Finance & Operations) Sell 275 shares, Carr Douglas (SVP Finance & Operations) Sell 1,654 shares, Russotti Gregory (See Remarks) Sell 2,584 shares, Pfeiffenberger Brent (President and CEO) Sell 13,849 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-18 | Pfeiffenberger Brent | President and CEO | Sell | 31,172 | $59,850 |
| 2026-08-05 | Carr Douglas | SVP Finance & Operations | Sell | 275 | $544 |
| 2026-06-15 | Carr Douglas | SVP Finance & Operations | Sell | 1,654 | $3,692 |
| 2026-06-15 | Russotti Gregory | See Remarks | Sell | 2,584 | $5,767 |
| 2026-06-15 | Pfeiffenberger Brent | President and CEO | Sell | 13,849 | $31,022 |
| 2026-06-15 | Cowan Chad | Chief Scientific Officer | Sell | 358 | $802 |
| 2026-06-09 | Carr Douglas | SVP Finance & Operations | Sell | 249 | $526 |
| 2026-06-09 | Russotti Gregory | See Remarks | Sell | 524 | $1,106 |
| 2026-06-09 | Pfeiffenberger Brent | President and CEO | Sell | 463 | $986 |
| 2026-05-19 | Pfeiffenberger Brent | President and CEO | Sell | 31,172 | $72,942 |
| 2026-05-06 | Carr Douglas | SVP Finance & Operations | Sell | 264 | $618 |
| 2026-04-03 | Cowan Chad | Chief Scientific Officer | Sell | 1,365 | $2,989 |
| 2026-03-16 | Russotti Gregory | See Remarks | Sell | 10,076 | $25,694 |
| 2026-03-16 | Carr Douglas | SVP Finance & Operations | Sell | 7,043 | $17,960 |
| 2026-03-13 | Pfeiffenberger Brent | President and CEO | Sell | 55,397 | $151,234 |
| 2026-03-13 | Cowan Chad | Chief Scientific Officer | Sell | 1,431 | $3,907 |
| 2026-03-11 | Russotti Gregory | See Remarks | Sell | 479 | $1,217 |
| 2026-03-11 | Carr Douglas | SVP Finance & Operations | Sell | 247 | $627 |
| 2026-03-10 | Pfeiffenberger Brent | President and CEO | Sell | 463 | $1,185 |
| 2026-02-18 | Pfeiffenberger Brent | President and CEO | Sell | 31,172 | $54,551 |
| 2026-02-05 | Carr Douglas | SVP Finance & Operations | Sell | 323 | $588 |
| 2026-02-04 | Cowan Chad | Chief Scientific Officer | Buy | 135,000 | $0 |
| 2026-02-04 | Pfeiffenberger Brent | President and CEO | Buy | 475,000 | $0 |
| 2026-02-04 | Carr Douglas | SVP Finance & Operations | Buy | 110,000 | $0 |
| 2026-02-04 | Russotti Gregory | See Remarks | Buy | 135,000 | $0 |
Source: SEC Form 4 filings · as of 2026-08-18